Sanofi Delivers 2017 Business EPS(1) in line with Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Sanofi (SNY) Reports Q4 EPS of EUR1.06
February 7, 2018 6:47 AM ESTSanofi (NYSE: SNY) reported Q4 EPS of EUR1.06, EUR0.09 worse than the analyst estimate of EUR1.15. Revenue for the quarter came in at EUR8.69 billion versus the consensus estimate of EUR8.67 billion.
Sanofi expects 2018 business EPS(1) to grow between 2% and 5%(7) at CER, including the... More
